Interesting facts
Interesting Facts About 2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)piperazin-1-yl]ethanol
This complex compound, often associated with pharmaceutical research, is drawing interest due to its potential pharmacological applications. Here are some engaging insights:
- Diverse Molecular Structure: The compound features multiple functional groups including a piperazine ring and a benzazepine moiety, making it a fascinating subject for studying structure-activity relationships.
- Psychotropic Potential: High relevance in medicinal chemistry, compounds like this one are often researched for their impacts on neurological pathways. They may modulate neurotransmitter systems, which can influence mood and cognition.
- Drug Design: Its unique structure allows for exploration in drug design, particularly targeting disorders such as anxiety and depression. Researchers are keen to understand how modifications to its structure can enhance efficacy or reduce side effects.
- Interdisciplinary Interest: This compound exemplifies the intersections between organic chemistry, pharmacology, and medicinal chemistry, making it of interest not just to chemists but also to biologists and pharmacologists.
- Historical Context: The benzo[b][1]benzazepine framework has historical significance in the development of various therapeutic agents, highlighting how earlier discoveries continue to inform modern drug development.
In summary, 2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)piperazin-1-yl]ethanol embodies a rich tapestry of chemical functionality, medicinal applications, and research opportunities. As scientists continue to explore its capabilities, it remains an intriguing candidate in the quest for better therapeutic agents.
Synonyms
Opipramol
315-72-0
Nisidana
Opipramol G
Opipramolum
Opramidol
Insidon
Endison
Opipramol dura
Insidon, base
Opipramol [INN:BAN]
Opipramolum [INN-Latin]
Insidon (free base)
Pramolan (free base)
1-Piperazineethanol, 4-[3-(5H-dibenz[b,f]azepin-5-yl)propyl]-
NSC 169867
2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)piperazin-1-yl]ethanol
EINECS 206-254-0
UNII-D23ZXO613C
Opipramol (INN)
NSC-169867
BRN 0627076
D23ZXO613C
4-(3-(5H-Dibenz(b,f)azepin-5-yl)propyl)-1-piperazineethanol
Insidon (Salt/Mix)
Opipramol dura (TN)
Pramolan (Salt/Mix)
OPIPRAMOL [INN]
OPIPRAMOL [MI]
OPIPRAMOL [WHO-DD]
1-PIPERAZINEETHANOL, 4-(3-(5H-DIBENZ(b,f)AZEPIN-5-YL)PROPYL)-
5H-Dibenz(b,f)azepine, 5-(3-(4-(2-hydroxyethyl)-1-piperazinyl)propyl)-
GR 33040
CHEMBL370753
N-(3-(4-(2-Hydroxyethyl)piperazino)propyl)iminostilbene
DTXSID3023394
5-23-01-00475 (Beilstein Handbook Reference)
G 33040
4-[3-(5H-Dibenz[b,f]azepin-5-yl)propyl]-1-piperazineethanol
Opipramolum (INN-Latin)
Insidon (TN)
N-[3-[4-(2-Hydroxyethyl)piperazino]propyl]iminostilbene
N-[3-[4-(2-Hydroxyethyl)-piperazino]propyl]iminostilbene
Opipramolo
NCGC00162068-04
N-(3-(4-(2-Hydroxyethyl)-piperazino)propyl)iminostilbene
2-(4-(3-(5H-dibenz(b,f)azepin-5-yl)propyl)piperazin-1-yl)ethanol
2-(4-(3-benzo(b)(1)benzazepin-11-ylpropyl)piperazin-1-yl)ethanol
2-{4-[3-(5H-dibenz[b,f]azepin-5-yl)propyl]piperazin-1-yl}ethanol
2-(4-(3-(2-azatricyclo(9.4.0.0^(3,8))pentadeca-1(15),3,5,7,9,11,13-heptaen-2-yl)propyl)piperazin-1-yl)ethan-1-ol
2-[4-(3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-yl}propyl)piperazin-1-yl]ethan-1-ol
Opipramol (Standard)
Opipramol Free Base
Oprea1_247234
SCHEMBL49841
Opipramol, analytical standard
DTXCID203394
CHEBI:94614
GTPL11247
N06AA05
BDBM50170636
MFCD00865455
NSC169867
AKOS003588969
DB12930
FO26574
HY-118901R
SDCCGSBI-0633687.P001
NCGC00162068-01
NCGC00162068-02
NCGC00162068-05
NCGC00162068-09
AC-15972
DA-56474
MS-25790
1ST161646
HY-118901
1-Piperazineethanol,f]azepin-5-yl)propyl]-
CS-0077653
NS00010442
WLN: T C676 BNJ B3-AT6N DNTJ D2Q
D08297
G78301
EN300-18531271
Q416562
BRD-K43786866-300-02-3
Z2216903864
4-[3-(5H-Dibenz[b,f]azepin-5-yl)propyl]-1-piperazinethanol
2-[4-(3-Dibenzo[b,f]azepin-5-yl-propyl)-piperazin-1-yl]-ethanol
5H-Dibenz[b, 5-[3-[4-(2-hydroxyethyl)-1-piperazinyl]propyl]-
2-(4-[3-(5H-Dibenzo[b,f]azepin-5-yl)propyl]-1-piperazinyl)ethanol #
2-[4-[3-(11-benzo[b][1]benzazepinyl)propyl]-1-piperazinyl]ethanol
2-{4-[3-(5H-dibenz[b,f]azepin-5- yl)propyl]piperazin-1-yl}ethanol
2-{4-[3-(5H-dibenzo[b,f]azepin-5-yl)propyl]piperazin-1-yl}ethanol
2-[4-(3-{2-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl}propyl)piperazin-1-yl]ethan-1-ol
206-254-0
4-[3-(5H-Dibenz[b,f]azepin-5-yl)propyl]-1-piperazineethanol;N-[3-[4-(2-Hydroxyethyl)piperazino]propyl]iminostilbene
Solubility of 2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)piperazin-1-yl]ethanol
The solubility of 2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)piperazin-1-yl]ethanol in various solvents is an important aspect to consider when evaluating its potential applications. This compound, known for its complex structure, exhibits unique solubility characteristics that are influenced by several factors:
As a result, one may quote that “under varying conditions, the solubility of complex organic compounds such as this one can oscillate significantly.” Understanding these factors is crucial for optimizing its use in pharmacological contexts or various formulations.
Therefore, evaluating the solubility of 2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)piperazin-1-yl]ethanol is essential for ensuring effective application and efficacy in scientific research and development.